Skip to content

Evaluation of the Efficacy of Preoperative Ketamine Nebulization on Postoperative Sore Throat Due to Tracheal Intubation for Adult Patients Under General Anesthesia, A Prospective Randomized Controlled Study

Evaluation of the Efficacy of Preoperative Ketamine Nebulization on Postoperative Sore Throat Due to Tracheal Intubation for Adult Patients Under General Anesthesia, A Prospective Randomized Controlled Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05975346
Enrollment
80
Registered
2023-08-03
Start date
2023-08-31
Completion date
2024-01-31
Last updated
2023-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Sore Throat

Brief summary

Sore throat includes specific symptoms such as dysphagia, dysphonia, hoarseness, continuous throat pain, and pharyngeal dryness. Patients rated postoperative sore throat (POST) as the eighth most undesirable outcome in the postoperative period POST has a reported incidence of up to 62% following general anesthesia (GA). The incidence of POST is more common in GA with tracheal intubation than in GA with the supraglottic airway Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist and has been used as a gargle for reducing the incidence and severity of POST due to its anti-nociceptive and anti-inflammatory effects

Interventions

DRUGKetamine

description

description

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 60 Years

Inclusion criteria

1. Age 16-60 years. 2. Of both sex. 3. American Society of Anesthesiologists Physical Status (ASA PS) I-II. 4. Undergoing general anesthesia with endotracheal intubation with surgery duration less than two hours.

Exclusion criteria

* a- History of chronic obstructive History of sore throat or upper respiratory tract infection. b- Intraoral and intrapharyngeal surgery. c- airway disease or Asthma. d- Mallampati grade more than II. e- Known allergic to study drug. f- More than one attempt is required for intubation. g- Hypertensive patients. h- Epileptic patients. i- cerebral palsy or any neurological disorders. j- Psychiatry patients. k- Cardiac patients. l- Perioperative use of anti-inflammatory drugs (Non-steroidal anti-inflammatory drug or steroids).

Design outcomes

Primary

MeasureTime frameDescription
the incidence and severity of POSTat immediate recovery (0 h), 2, 4, 6, 8, 12 and 24 h post-operatively.the study is to measure the incidence and severity of POST at immediate recovery (0 h), 2, 4, 6, 8, 12 and 24 h post-operatively. in adult patients undergoing surgery of a duration less than 2h.

Secondary

MeasureTime frameDescription
evaluation of side effects including nausea, vomiting, cough, and dry mouth in both groups.at immediate recovery (0 h), 2, 4, 6, 8, 12 and 24 h post-operatively.evaluation of side effects including nausea, vomiting, cough, and dry mouth in both groups.

Contacts

Primary ContactDoaa A Abdellatif, resident
doaaahmed@med.sohag.edu.eg01119950167
Backup Contactfawzy A Badawy, assistant professor
01004862474

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026